TY - JOUR
T1 - Notch Signaling Promotes Mature T-Cell Lymphomagenesis
AU - Gao, Xin
AU - Wang, Chenguang
AU - Abdelrahman, Suhaib
AU - Kady, Nermin
AU - Murga-Zamalloa, Carlos
AU - Gann, Peter
AU - Sverdlov, Maria
AU - Wolfe, Ashley
AU - Polk, Avery
AU - Brown, Noah
AU - Bailey, Nathanael G.
AU - Inamdar, Kedar
AU - Casavilca-Zambrano, Sandro
AU - Montes, Jaime
AU - Barrionuevo, Carlos
AU - Taxa, Luis
AU - Reneau, John
AU - Siebel, Christian W.
AU - Maillard, Ivan
AU - Wilcox, Ryan A.
N1 - Publisher Copyright:
©2022 American Association for Cancer Research.
PY - 2022/10/17
Y1 - 2022/10/17
N2 - Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis. SIGNIFICANCE: This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
AB - Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis. SIGNIFICANCE: This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.
UR - http://www.scopus.com/inward/record.url?scp=85140144178&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-22-1215
DO - 10.1158/0008-5472.CAN-22-1215
M3 - Artículo
C2 - 36006995
AN - SCOPUS:85140144178
SN - 0008-5472
VL - 82
SP - 3763
EP - 3773
JO - Cancer Research
JF - Cancer Research
IS - 20
ER -